Indication
Coronavirus Infection
19 clinical trials
21 products
1 drug
Clinical trial
Phase 1/2a Study of Umbilical Cord Lining Stem Cells (ULSC) in Patients With ARDS Due to COVID-19Status: Completed, Estimated PCD: 2023-05-12
Product
BaricitinibClinical trial
A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients From 1 Year to Less Than 18 Years Old Hospitalized With COVID-19Status: Recruiting, Estimated PCD: 2024-07-14
Product
EbselenClinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of SPI-1005 in Severe COVID-19 PatientsStatus: , Estimated PCD: 2023-12-31
Product
PlaceboProduct
ZofinClinical trial
A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Zofin for the Treatment of Moderate to SARS Related to COVID-19 Infection vs PlaceboStatus: Completed, Estimated PCD: 2023-07-01
Clinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety and Efficacy of SPI-1005 in Moderate COVID-19 PatientsStatus: , Estimated PCD: 2023-12-31
Product
COVAXIN(BBV152)Product
BBV154Product
Treatment administrationClinical trial
A Phase IIb, Double Blind, Placebo-controlled Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19Status: Completed, Estimated PCD: 2023-01-21
Clinical trial
Phase 2 Randomized, Multi-centric of Heterologus Prime-Boost Combination of SARS-CoV-2 Vaccines to Evaluate the Immunogenicity and Safety of BBV152 (COVAXIN®) With BBV154 (Adenoviral Intranasal COVID-19 Vaccine) in Healthy VolunteersStatus: Completed, Estimated PCD: 2022-03-01
Clinical trial
Training the Innate Immune System Against SARS-COV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents: A Randomized, Doubled-Blinded, Comparative Group Observational StudyStatus: Completed, Estimated PCD: 2021-12-30
Product
SHINGRIXProduct
Normal SalineClinical trial
Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS: A Randomized, Placebo Controlled, Multicenter TrialStatus: Terminated, Estimated PCD: 2023-06-14
Product
AviptadilProduct
Placebo 0.9% NaCl solutionClinical trial
A Randomized, Double-Blind, Placebo-Controlled Phase IIa Study of Quintuple Therapy to Treat COVID-19 InfectionStatus: Completed, Estimated PCD: 2024-02-27
Product
HydroxychloroquineProduct
AzithromycinClinical trial
Assessing Safety of COVID-19 mRNA Vaccine Administration in the Setting of a Previous Adverse ReactionStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 PatientsStatus: Completed, Estimated PCD: 2021-10-31
Product
Stem CellsClinical trial
Understanding Immunity to the Flu Vaccine in COVID-19 PatientsStatus: Recruiting, Estimated PCD: 2026-03-01
Product
FluClinical trial
ZYESAMI (Aviptadil) for the Treatment of Critical COVID-19 With Respiratory FailureStatus: Completed, Estimated PCD: 2021-02-22
Clinical trial
A Phase I/II Dose-escalation Multi Center Study to Evaluate the Safety of Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in coronaviruS pnEumonia and/or LymphopeniaStatus: Completed, Estimated PCD: 2022-01-13
Product
T memory cells and NK cellsClinical trial
Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19Status:
Product
Convalescent PlasmaClinical trial
A Multicenter Randomized Trial to Assess the Efficacy of CONvalescent Plasma Therapy in Patients With Invasive COVID-19 and Acute Respiratory Failure Treated With Mechanical Ventilation: the CONFIDENT TrialStatus: Active (not recruiting), Estimated PCD: 2022-04-09
Clinical trial
Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 PandemiaStatus: Terminated, Estimated PCD: 2022-03-17
Product
LidocaineDrug
VarlilumabClinical trial
Effect of Pentoxifylline on Immune-inflammation Index for Predicting Prognosis of Coronavirus Disease 2019 (COVID- 19) InfectionStatus: Completed, Estimated PCD: 2021-06-01
Product
Pentoxifylline